Anti-angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells-Reference-Cited by-同舟云学术

Anti-angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells

Published:2018-05-08 Issue:6 Volume:47 Page:575-582
ISSN:0904-2512
Container-title:Journal of Oral Pathology & Medicine
language:en
Short-container-title:J Oral Pathol Med

Author:

Ganjibakhsh Meysam¹,Monshizadeh Roshanak²,Nasimian Ahmad³,Aminishakib Pouyan²⁴^ORCID,Farzaneh Parvaneh¹,Tavakoli Shiraji Sahar⁵,Gharajei Ata⁶⁷,Rahrotaban Sedigheh²,Baghaei Fereshteh⁴,Gohari Neda Sadat¹

Affiliation:

1. Human and Animal Cell Bank; Iranian Biological Resource Center (IBRC); ACECR; Tehran Iran

2. Department of Oral and Maxillofacial Pathology; School of Dentistry; Tehran University of Medical Sciences; Tehran Iran

3. Department of Clinical Biochemistry; School of Medical Sciences; Tarbiat Modares University; Tehran Iran

4. Dental Research Center; Dentistry Research Institute; Tehran University of Medical Sciences; Tehran Iran

5. Hematology, Oncology and SCT Research Center; Tehran University of Medical Sciences; Tehran Iran

6. Department of Oral and Maxillofacial Surgery; School of Dentistry; Tehran University of Medical Sciences; Tehran Iran

7. Department of Head and Neck Surgical Oncology and Reconstructive Surgery; The Cancer Institute, School of Medicine; Tehran University of Medical Sciences; Tehran Iran

Funder

Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences

Academic Center for Education, Culture and Research

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jop.12717/fullpdf

Reference28 articles.

1. Pharmacotherapyof head and neck squamous cell carcinoma;Pan;Expert Opin Pharmacother,2009

2. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma;Yin;Head Neck,2011

3. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives;Ausoni;Cancer Metastasis Rev,2016

4. VEGF-Trap: a VEGF blocker with potent antitumor effects;Holash;Proc Natl Acad Sci U S A,2002

5. Aflibercept a new target therapy in cancer treatment: a review;Ricci;Crit Rev Oncol Hematol,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview;Cells;2024-07-31

2. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02

3. Immunology of Oral Squamous Cell Carcinoma—A Comprehensive Insight with Recent Concepts;Life;2022-11-07

4. The therapeutic potential of adipose tissue-derived mesenchymal stromal cells in the treatment of busulfan-induced azoospermic mice;Journal of Assisted Reproduction and Genetics;2021-09-14

5. The effect of aflibercept and arsenic trioxide on the proliferation, migration and apoptosis of oral squamous cell carcinoma in vitro;Molecular Biology Reports;2021-04